Brii Biosciences Ltd (HKSE:02137)
HK$ 1.09 0 (0%) Market Cap: 795.53 Mil Enterprise Value: -2.06 Bil PE Ratio: 0 PB Ratio: 0.23 GF Score: 19/100

Full Year 2022 Brii Biosciences Ltd Earnings Call Transcript

Mar 24, 2023 / 12:00PM GMT
Release Date Price: HK$5.03 (-2.33%)
Chris Fang
- IR Director

Full Year 2022 Earnings Conference Call. Our full year results announcement can be found on the Investor Relations section of our company website.

(Operator Instructions) Please be advised that today's conference call may be recorded. This is Chris Fang, Director of Investor Relations. Joining us today on the call from Brii Bio's Executive Management team are Zhi Hong, Chairman and CEO; Dr. Li Yan, Chief Medical Officer; and Dr. Ankang Li, Chief Strategy and Financial Officer.

Dr. Hong will first provide us an overview covering our strategic pipeline, priorities and business developments. Followed by Dr. Yan, who will review our clinical programs in China and in the U.S. Dr. Li will then go over our financial status. We will then open the call for questions at which time, we will be joined by Dr. Susannah Cantrell, Chief Business Officer; Dr. Eleanor de Groot, Chief Technology Officer; Qing Zhu, Head of China R&D; and Dr. David Margolis, our Infectious Disease TA head.

Before we start, I would like to remind you that today's conference may be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot